Showing results (241-250 of 411) with videos related to
Sort By:
Pageof 42
Alzheimer'S Research & Therapy|February 2, 2019
Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD studyFatemah A Sakr, Michel J Grothe, Enrica Cavedo, et al.Expert Review of Proteomics|February 5, 2021
Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseasesNicole Campese, Giovanni Palermo, Claudia Del Gamba, et al.Plos One|March 3, 2012
Using support vector machines with multiple indices of diffusion for automated classification of mild cognitive impairmentLaurence O'Dwyer, Franck Lamberton, Arun L W Bokde, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 29, 2018
Association of cerebrospinal fluid α-synuclein with total and phospho-tau<sub>181</sub> protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkersAndrea Vergallo, René-Sosata Bun, Nicola Toschi, et al.Journal of Managed Care & Specialty Pharmacy|July 24, 2025
Real-world health care costs and resource utilization associated with mild cognitive impairment in the United States: A retrospective cohort study of commercial and Medicare dataFeride H Frech, Gang Li, Timothy R Juday, et al.Neurobiology of Aging|April 16, 2020
In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer's diseaseStefan J Teipel, Martin Dyrba, Patrizia A Chiesa, et al.Journal of Alzheimer'S Disease : JAD|June 23, 2011
Using diffusion tensor imaging and mixed-effects models to investigate primary and secondary white matter degeneration in Alzheimer's disease and mild cognitive impairmentLaurence O'Dwyer, Franck Lamberton, Arun L W Bokde, et al.Alzheimer'S Research & Therapy|November 13, 2020
Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up studyFilippo Baldacci, Simone Lista, Maria Laura Manca, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 28, 2024
Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's diseaseViswanath Devanarayan, Thomas Doherty, Arnaud Charil, et al.Journal of Alzheimer'S Disease : JAD|July 13, 2012
Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's diseasePascale Fehlbaum-Beurdeley, Olivier Sol, Laurent Désiré, et al.Pageof 42